# clm_932289F9A641

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_operating_income  
value: 622,188,000 United States dollar  
valid_from: 2018-06-30  
valid_to: 2018-09-30  
published: 2018-08-02  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_56C5E89651F4  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly operating income: 622,188,000 United States dollar", as of 2018-06-30 (until 2018-09-30). Claim clm_932289F9A641, https://asof.is/claim/clm_932289F9A641, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217618000028/0001532176-18-000028-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2018, filed 2018-08-02  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000153217618000028/0001532176-18-000028-index.htm (primary, SEC EDGAR 10-Q Q2 FY2018, published 2018-08-02)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 567,231,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_932289F9A641](/claim/clm_932289F9A641.md) | [clm_8FA9C48DB5EF](/claim/clm_8FA9C48DB5EF.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.